Maure-Blesa, L, Carmona-Iragui, M, Lott, I, Head, E, Wisniewski, T, Rafii, MS, Espinosa, J, Flórez, J, Mobley, WC, Holland, A, Strydom, A, Zaman, S, Fortea, J. The history of Down syndrome-associated Alzheimer's disease; past, present, and future. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70158. PMID:40469048. IF:11.100(Q1/1D).

Liu, XL, de Boer, SCM, Cortez, K, Poos, JM, Illán-Gala, I, Heuer, H, Forsberg, LK, Casaletto, K, Memel, M, Appleby, BS, Barmada, S, Bozoki, A, Clark, D, Cobigo, Y, Darby, R, Dickerson, BC, Domoto-Reilly, K, Galasko, DR, Geschwind, DH, Ghoshal, N, Graff-Radford, NR, Grant, IM, Hsiung, GYR, Honig, LS, Huey, ED, Irwin, D, Kantarci, K, Léger, GC, Litvan, I, Mackenzie, IR, Masdeu, JC, Mendez, MF, Onyike, CU, Pascual, B, Pressman, P, Bayram, E, Ramos, EM, Roberson, ED, Rogalski, E, Bouzigues, A, Russell, LL, Foster, PH, Ferry-Bolder, E, Masellis, M, van Swieten, J, Jiskoot, L, Seelaar, H, Sanchez-Valle, R, Laforce, R, Graff, C, Galimberti, D, Vandenberghe, R, de Mendonça, A, Tiraboschi, P, Santana, I, Gerhard, A, Levin, J, Sorbi, S, Otto, M, Pasquier, F, Ducharme, S, Butler, CR, Le Ber, I, Finger, E, Rowe, JB, Synofzik, M, Moreno, F, Borroni, B, Boeve, BF, Boxer, AL, Rosen, HJ, Pijnenburg, YAL, Rohrer, JD, Tartaglia, MC. Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.14608. PMID:40277074. IF:11.100(Q1/1D).

Smith, RG, Pishva, E, Kouhsar, M, Imm, J, Dobricic, V, Johannsen, P, Wittig, M, Franke, A, Vandenberghe, R, Schaeverbeke, J, Freund-Levi, Y, Frölich, L, Scheltens, P, Teunissen, CE, Frisoni, G, Blin, O, Richardson, JC, Bordet, R, Engelborghs, S, de Roeck, E, Martinez-Lage, P, Altuna, M, Tainta, M, Lleó, A, Sala, I, Popp, J, Peyratout, G, Winchester, L, Nevado-Holgado, A, Verhey, F, Tsolaki, M, Andreasson, U, Blennow, K, Zetterberg, H, Streffer, J, Vos, SJB, Lovestone, S, Visser, PJ, Bertram, L, Lunnon, K. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study. ALZHEIMERS & DEMENTIA. 2024; 20(10)DOI:10.1002/alz.14098. PMID:39193893. IF:11.100(Q1/1D).

Bellver-Sanchis, A, Valle-Garcia, D, Barbaraci, C, Romero-Becerra, F, Singh, RK, Jarne-Ferrer, J, Vasilopoulou, F, Irisarri, A, Martínez-Fernández, C, Fafián-Labora, JA, Arufe, MC, Wüst, C, Castellanos, A, Soto, D, Casals, N, Fadó, R, Pocock, JM, Navarro, G, Val, C, Brea, J, Loza, MI, Lleó, A, Fortea, J, Alcolea, D, Perez-Bosque, A, Miró, L, Pérez, B, Rashid, S, Ali, M, Saqib, M, li Carbó, M, Guerrero, A, Vázquez, S, Choudhary, BS, Dai, SD, Escolano, C, Franco, R, Pallàs, M, Griñán-Ferré, C. First-in-class SAM-competitive G9a inhibitor FLAV-27 as adisease-modifying therapy for Alzheimer disease. MOLECULAR THERAPY. 2026; 34(4)DOI:10.1016/j.ymthe.2025.12.038. PMID:41445192. IF:12.000(Q1/1D).

Figueredo, LF, Chen, JY, Gaggi, NL, Song, XT, Jacobs, T, Silva-Albornoz, G, Pehel, S, Gonzalez, M, Badia, SG, Rosenzweig, I, Naismith, SL, Ramos-Cejudo, J, Gills, J, Ayappa, I, Rapoport, DM, Kam, K, Mullins, AE, Parekh, A, Varga, AW, Bubu, OM, Blessing, E, Novikov, DS, Fieremans, E, Osorio, RS. White matter microstructure differences in obstructive sleep apnea severity groups assessed by diffusion tensor metrics and biophysical modeling. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-026-39162-7. PMID:41781414. IF:3.900(Q1/2D).

Perovnik, M, Simoncic, U, Jamsek, J, Kramberger, MG, Brumberg, J, Meyer, PT, Perani, D, Caminiti, SP, Brendel, M, Stockbauer, AC, Camacho, V, Alcolea, D, Vandenberghe, R, Van Laere, K, Ko, JH, Lee, CS, Pardini, M, Lombardo, L, Padovani, A, Pilotto, A, Ochoa-Figueroa, MA, Davidsson, A, Cháfer-Pericás, C, Alvarez-Sánchez, L, Garibotto, V, Lemstra, AW, Ferreira, D, Morbelli, SD, Tang, CC, Eidelberg, D, Trost, M. Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2026; 97(4)DOI:10.1136/jnnp-2025-336935. PMID:41344886. IF:7.500(Q1/1D).

Morcillo-Nieto, AO, Rozalem-Aranha, M, Maure-Blesa, L, Rodríguez-Baz, I, Arriola-Infante, JE, Franquesa-Mullerat, M, Zsadanyi, SE, Vaqué-Alcázar, L, Parra, JA, Zhao, ZL, Arranz, J, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Pertierra, L, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2026; 22(2)DOI:10.1002/alz.71157. PMID:41639041. IF:11.100(Q1/1D).

Bolsewig, K, Bellomo, G, Hok-A-Hin, YS, Al Idrissi, I, Vermunt, L, Lleó, A, Alcolea, D, Sieben, A, Engelborghs, S, Simonsen, AH, Hasselbalch, SG, Bech, S, Morrema, THJ, Hoozemans, JJM, Bol, JGJM, Van Alphen, J, Gaetani, L, Chiasserini, D, Paoletti, FP, Parnetti, L, Kang, SW, Lee, YG, Jeon, S, Lee, AH, Jeon, S, Ye, BS, Milán, MD, Van Der Flier, WM, Van De Berg, WDJ, Lemstra, AW, Willemse, EAJ, Teunissen, CE. A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. NATURE MEDICINE. 2026; 32(3)DOI:10.1038/s41591-026-04212-0. PMID:41699128. IF:50.000(Q1/1D).